Navigation Links
Boffins Identify Gene That Helps Regulates Body Weight

Boffins have found that the absence of CD38 gene prevented mice on high-fat diets from gaining weight.

The study was conducted by a team of researchers led by Eduardo Chini at Mayo Clinic.

As part of the study, researchers studied two groups of mice - one with the gene CD38 and the other without. Each group was fed a high-calorie diet with 60 percent of calories from fat. In a second test, each group was fed a standard diet in which 4 percent of calories came from fat.

Researchers found that the body fat of mice that carried CD38 and were on a high-fat diet nearly quadrupled and their body weight almost doubled. After eight weeks on a high-fat diet, mice with CD38 began to show signs of glucose intolerance, one of the first indicators of diabetes onset.

In addition, this group of mice lived for only four-to-six months compared to the second group of mice that lived for 12 months.

The study noted that for the group of mice that had no CD38, the body fat and weight did not change even though they were on a high fat diet. These mice burned more energy, were leaner and otherwise healthy. he researchers also examined the effects of resveratrol in mice.

Resveratrol is a naturally occurring substance found in some plants such as mulberries, peanuts and red grapes used to make wine. It has been marketed as a drug that mimics the effects of moderate exercise without the physical act of exercising and also as a longevity drug, despite the lack of evidence that resveratrol is safe and effective in humans.

Researchers treated mice with CD38 with 30 milligrams of resveratrol per day and to determine the effects of the SIRT genes on obesity, mice without CD38 received the same dose of sirtinol, a drug that shuts down the SIRT genes.

Researchers found that mice with CD38 that were treated with resveratrol for two weeks were protected from high-fat, diet-induced obesit
'"/>




Page: 1 2

Related medicine news :

1. Fizzy Logic For A Perfect Drink: Courtesy Boffins
2. Boffins Identify Fifth Gene Behind Joubert Syndrome
3. Boffins Find Link Between Common Sleep Disorder and Hypertension
4. Boffins Identify Molecule That Might Treat Food Allergy
5. Boffins a Step Closer to Solving Puzzle of Lou Gehrigs Disease
6. Boffins Link Atkins Diet With Bowel Cancer
7. Boffins Develop New Technique to Hunt Illness-causing Mutants in Non-gene DNA
8. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
9. Identifying bacteria made amiable
10. Identifying brain lesions with impaired consciousness
11. Identifying Virus Found To Be Essential for HIV Patients
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Boffins Identify Gene That Helps Regulates Body Weight

(Date:7/28/2014)... Dennis Thompson ... News) -- Babies born prematurely appear to have a ... they will carry into adulthood, Swedish researchers report. ... 37 weeks, gestation have a raised risk of deep ... by blood clotting in the veins, the researchers noted ...
(Date:7/28/2014)... A new study, published in the July, 2014, ... Cancer Institute by Northwestern Medicine researchers, sheds ... growing popularity of endoscopic resection in the treatment ... the more traditional surgical resection, while more invasive, ... five-year survival rate for patients than endoscopic resection, ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 A young ... to the all-too-often stories in the media today about ... occur in a matter of minutes in a hot ... to the Office of Emergency Medical Services at NHTSA. ... app for smartphones. Realizing that it’s all too easy ...
(Date:7/28/2014)... Irresistible infants have met their match with a darling ... gifting company specializes in homemade chicken noodle soup and creates bundles ... starts with home-from-the-hospital essentials every new parent will love:, ... , 6 cookies , a ladle to ... to heat and eat upon delivery, so parents can relax and ...
(Date:7/28/2014)... Albany, New York (PRWEB) July 28, 2014 ... Transparency Market Research "E-Clinical Solution Software Market- Global Industry ... 2020," the global microfluidic device market was valued at ... grow at a CAGR of 13.8% from 2014 to ... million in 2020. , Globally, the e-clinical solution software ...
Breaking Medicine News(10 mins):Health News:Preemies May Have Higher Risk of Blood Clots, Even as Adults 2Health News:Preemies May Have Higher Risk of Blood Clots, Even as Adults 3Health News:Study helps compare risks of treatments for early esophageal cancer 2Health News:Study helps compare risks of treatments for early esophageal cancer 3Health News:'Precious Cargo' App Released to Help Save Babies from the Dangers of Being Accidentally Left Behind in Hot Cars 2Health News:Spoonful of Comfort Announces "New Baby" Gift Package 2Health News:Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Health News:Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Health News:Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 4
... Stereotaxis, Inc.,(Nasdaq: STXS ) today announced ... institutional investors to raise gross proceeds of $20,million through ... separate,concurrent transactions. A portion of the warrants sold will ... warrants would provide an additional,approximately $10 million in gross ...
... about possible outcomes, study finds , , MONDAY, Dec. 29 ... ill patients want doctors to frankly discuss the patient,s prognosis ... , The University of San Francisco Medical Center study, ... Journal of Respiratory and Critical Care Medicine , points out ...
... Calif., Dec. 29 Accuray Incorporated (Nasdaq: ... radiosurgery, announced today that its management is scheduled to ... in New York, on Wednesday, January 7, 2009 at ... the presentation will be available online from the investor ...
... LCAV ) Board of Directors strongly opposes the consent ... that the Company has undertaken a prudent and achievable strategic ... Joffe intervention is a poorly designed effort to take control ... Joffe effort is an undue distraction to the Company that ...
... Directory on Internet - , , ANTHEM, Ariz., ... announced launch of its new web site at http://www.mychoicedentist.com ... in the Phoenix , Arizona, area is proceeding successfully. ... Chris Theotocatos, CEO. "We anticipate expanding this service to almost ...
... Plans New Products and Expanded Services in 2009 , ... ... has reported its seventh consecutive year of revenue growth in 2008, ... demand for media relations and marketing services provided by its HRmarketer ...
Cached Medicine News:Health News:Stereotaxis to Raise $20 Million in Registered Direct Offering of Common Stock and Warrants 2Health News:Stereotaxis to Raise $20 Million in Registered Direct Offering of Common Stock and Warrants 3Health News:Stereotaxis to Raise $20 Million in Registered Direct Offering of Common Stock and Warrants 4Health News:Family Needs to Know When Patient Survival Is Uncertain 2Health News:Accuray Incorporated to Present at 11th Annual Needham Growth Stock Conference 2Health News:LCA-Vision Urges Stockholders to Take No Action Regarding the Joffe Group's Threatened Consent Solicitation 2Health News:Prime Companies Announces Launch of New Dental Web Site 2Health News:Fisher Vista, LLC Reports Seventh Consecutive Year of Revenue Growth and Profitability 2Health News:Fisher Vista, LLC Reports Seventh Consecutive Year of Revenue Growth and Profitability 3
(Date:7/28/2014)... Colo. , July 28, 2014  Array ... financial results for the fourth quarter and ... a conference call to discuss those results ... Chief Executive Officer and Michael Carruthers ... call.Conference Call InformationDate:Tuesday, August 12, 2014Time:9:00 a.m. ...
(Date:7/28/2014)... 28, 2014  Syneron Medical Ltd. (NASDAQ: ... today that its new PicoWay® device has received CE ... colors and pigmented lesions on any skin type. PicoWay ... 532nm and 1064nm wavelengths, which utilizes Syneron,s proprietary PicoWay ... which are trillionths of a second, known as picosecond ...
(Date:7/28/2014)... July 28, 2014  ResMed (NYSE: RMD ... the treatment of sleep-disordered breathing and other chronic respiratory ... Germany against Taiwanese medical device manufacturer APEX ... on APEX WiZARD 210 and 220 masks.  The judgment ... Munich , is appealable, and applies throughout ...
Breaking Medicine Technology:Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 2Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 3Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 4ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe 2
... 2011 K-V Pharmaceutical Company (the "Company") (NYSE: ... of Obstetricians and Gynecologists (ACOG) and Society for ... and ensure that healthcare providers, patients, and the ...  The information update from ACOG and SMFM confirms ...
... MONTREAL, Oct. 13, 2011 A Medco Health Solutions, ... found that 38 percent of patients prescribed Plavix® (clopidogrel)—an ... and stroke—were also using another drug that would impede ... The analysis also showed that primary care physicians ...
Cached Medicine Technology:K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 2K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 3K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 4K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 5K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 6K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 7K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 8Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 2Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 3Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 4
The all silicone construction of the shaft and neck flange provides the utmost in patient comfort. , ,The Aire-Cuf® tracheostomy tube offers a more traditional and familiar air-filled cuff desig...
... ISO termination for easy ventilator circuit attachment ... , ,Clearly the softer choice in ... ,The Portex® flexible disposable inner cannula ... chloride, providing a softer and more pliable ...
Indications For Usage: ,Bypass upper airway obstructions, provide long term ventilation, support and/or manage tracheal/bronchial secretions...
... Adult TRACH CARE Dual Lumen, ... at the patient end of ... Double Swivel Elbow and Direction ... port. Offers multiple tracheostomy sizes, ...
Medicine Products: